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Patients and Patience
“Efficient health care requires informed doctors and patients. The 
health care system inherited from the 20th century falls short on both 
counts” 
"(We have an)… inefficient system that wastes taxpayer's money on 
unecessary or even potentially harmful tests and treatments as well as 
on medical research that is of limited relevance to the patient"
Raise taxes? Ration resources? 
Patients and Patience
"The 21st century should become the century of the 
patient. …Promote health literacy and better care is 
possible for less money”
" (What’s needed)…. is honest and transparent 
information to enable better doctors, better 
patients and ultimately better health care"
› Chapter from "Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 
2020" edited by Gerd Gigerenzer and J.A. Muit Gray. MA. MIT Press (due out February 
2011)
Take for example, 
PSA screening for prostate cancer
THE BENEFIT
• ERSPC study found that the risk of dying from prostate 
cancer from 3.65 deaths per 1000 men over 9 years to 2.94 
deaths per 1000 men over 9 years.
• POTENTIAL HARMS
• Control group – 48/1000 men affected by prostate cancer 
diagnosis and treatment
• Screened group – 82/100 men
Schroder, F.H. et al., Screening and prostate cancer mortality in a randomised European study. New England 
Journal of Medicine, 2009, 360(13):1320-28
Take for example, 
PSA screening for prostate cancer
SNAPSHOT BENEFIT TO HARM RATIO
- 34 additional men diagnosed with prostate cancer and 
treated for LESS than one death per 1000 men
- 1410 men would need to be screened and 48 additional 
cases of prostate cancer would need to be treated to 
prevent a single death from prostate cancer.
Take for example, 
PSA screening for prostate cancer
The elephant in the room
- Put those 48 men in one room.
- "Each would be convinced that the detection and 
treatment of their prostate cancer had saved their life. 
And 47 of the 48 would be wrong"
Chapman S, Barratt A and Stockler M. Let Sleeping Dogs Lie. What men should know before getting 
tested for prostate cancer. Sydney University Press. 2010.
What is the possible response to this?
• Information support
• Yes, but written information is often presented in a bias way
• (insert ref to review)
• Decision support
• For patients, for doctors, - to achieve informed consent
• Growing recognition for more formal decision support
Affordable Health Care for America Act 
Affordable Health Care for America Act 
Affordable Health Care for America Act 
Key requirements in this legislation
› It's for 'patients' ….and clinicians
› Options 
› Scientific evidence
› Beliefs, preferences and values
› Trade-offs
› Educational tool
My talk today
› How to implement decision support using Multi Criteria 
Decision Analysis (MCDA) via an interactive aid - Annalisa  
Dr Michelle Cunich
A/Prof Kirsten Howard
Prof Jack Dowie
Declarations
MCDA collaborations using ‘Annalisa’ in London, Sydney and Odense
Declarations
› Jack Dowie, London School of Hygiene and Tropical Medicine, is a part owner 
of the IP of Annalisa ©
› MyDecisionSuite  and MyDecisionQuality are © 2011 Mette Kjer Kaltoft and 
Jack Dowie
› The Prostate Cancer Screening Annalisa was designed by 
› Glenn Salkeld and Michelle Cunich, University of Sydney 
› and Jack Dowie.
› The School of Public Health, University of Sydney has no precuniary interest 
in the software or licensing but does have a strong interest in research 
collaboration and open access to interactive decision support aids that have 
been evaluated.       AND……………….
DeclarationsI’m a BIG fan of BC!
What is MCDA?
Multi criteria methods to designed to help people make better choices when faced 
with complex decisions
Facilitates combination of ‘evidence’ and ‘subjective preferences’
• Decompose the decision problem
• Describe the attributes or characteristics of option
(or the criteria used to determine whether a decision goal is met)
Value-based methods use quantitative approaches to determine how well the 
options fulfill the criteria and decision priorities of the criteria in achieving the goal of 
the decision
Reference: Dolan  JG. Patient 2010 3(4)229-248
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Preparing for the decision
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Decision 
Technologies
Not
Decision- Aided
Decision-
Aided
Not
MCDA-based MCDA-based
AHP, HiView, 
Visa Annalisa 2+
Integrated in MDS
My Decision Aid
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Option
s
Option
s
Attributes
Evidence Base
Preference Base
Option Scores
My Decision Aid
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My Decision Aid
› PSA Annalisa – Demonstration Video
› http://www.screencast.com/t/MlNAbfcI
› Camtasia Studio\PSA Test SHort Demo V3\PSA Test SHort Demo V3.avi
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Low Numeracy
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Keep it simple
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Keep it simple
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Would you like to see the evidence?
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Reveal the scores
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Change the settings in Annalisa
30
Show the breakdown of the score
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Making health decisions –
it’s a complex and imperfect world
34
